Omega-3 fatty acids as component of nutritional and metabolic treatment of patients with COVID-19 and other viral diseases (literature review)

Nutritional deficit in patients with viral diseases, including COVID-19, can reduce the efficacy of specific treatment, decrease survival rate, and increase medical expenses. According to international guidelines, timely correction nutritional status supplemental enteral parenteral nutrition containing omega-3 polyunsaturated fatty acid from fish oil (omega-3 PUFAs: ЕРА DHA) is able improve clinical outcomes antiviral treatment. The authors conducted an analytical review assess results study use PUFAs for prevention treatment COVID-19 other infections. Supplementation (enteral parenteral) allows symptom reduction, shorter stay hospital, quicker recovery infected SARS-CoV-2 viruses. When used combination adequate macronutrient support, it reverse outcomes.